Aerie Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a fireside chat discussion at the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at 2:00 p.m. Easter